Biography
Laura C. Turano is a partner in the Corporate Department and a member of the firm’s Mergers & Acquisitions Group. Laura’s practice focuses on advising clients in connection with public and private company mergers and acquisitions, joint ventures, carve-outs and other significant transactions. She also advises clients on activist defense and corporate governance matters. Laura is Chair of the Women in Law Empowerment Forum (WILEF) East Young Lawyers Committee, a member of the Advisory Counsel of the NYU Law Institute for Corporate Governance & Finance and is an adjunct professor at NYU School of Law teaching mergers & acquisitions.
In 2023, Laura was named to Crain’s New York Business’ "40 under 40” and “Notable Women in Law”, recognized as a “U.S. Rising Star – Financial & Corporate” by LMG Life Sciences, an “MVP” in M&A by Law360 and as one of the “500 Leading Dealmakers in America” by Lawdragon. In 2022, Laura was recognized by Bloomberg Law in its “They’ve Got Next: 40 Under 40”, a finalist in American Lawyer’s Industry Awards for “Young Lawyer of the Year”, one of the “Top Women in Dealmaking” by The Deal, a “Rising Star” in M&A by Law360 and as one of the “500 Leading Dealmakers in America” by Lawdragon. In 2021, The American Lawyer named her “Dealmaker of The Year” for her role advising Teladoc Health in its acquisition of Livongo Health. Laura is also recognized in The Legal 500 for her work in Corporate/M&A.